ESR1 and triple-negative breast carcinoma: Inhibitory effect of compounds 5a–c and 5e against the human Molt 4/C8, CEM T-lymphocytes, murine P388, L1210, estrogen-receptor-positive breast cancer cells MCF-7, and the triple-negative breast cancer (TNBC) cells MDA-MB-231.